Our Manuscripts
Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors
Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy
P62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity
Broad-spectrum Anti-tumor and Anti-metastatic DNA Vaccine based on p62-encoding Vector
Pilot Study of p62 DNA Vaccine in Dogs with Mammary Tumors
Plasmid DNA-coding p62 as a Bone Effective Anti-inflammatory/Anabolic Agent
P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions
p62 /SQSTM1 coding plasmid prevents age related macular degeneration in a rat model
p62 / SQSTM1 Expression In Canine Mammary Tumours: Evolutionary Notes